한글목차

듀셴형 근이영양증(DMD) 치료 시장(2024-2028년)

듀셴형 근이영양증(DMD) 치료 시장은 2023-2028년 43억 7,330만 달러로 예측되며, 예측 기간 동안 28.21%의 CAGR로 성장할 것으로 예상됩니다. 듀센형 근이영양증(DMD) 치료 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. Duchenne 근이영양증 치료에 대한 높은 미충족 수요, 공급업체 간의 전략적 제휴 증가, 환자 지원 프로그램 도입 등이 시장을 주도하고 있습니다.

이 보고서는 강력한 듀셴형 근이영양증 치료제 파이프라인이 향후 몇 년 동안 듀셴형 근이영양증(DMD) 치료 시장의 성장을 촉진하는 주요 이유 중 하나로 꼽았습니다. 또한, 듀셴형 근이영양증 치료에 대한 연구 자금의 증가와 듀셴형 근이영양증(DMD) 치료제의 특효약 지정은 시장의 큰 수요를 창출할 것으로 예상됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023년
• 시장 전망 2023-2028년

제4장 시장 규모 실적

• 듀셴형 근이영양증(DMD) 치료 세계 시장 2018-2022년
• 유형별 부문 분석 2018-2022년
• 유통 채널별 부문 분석 2018-2022년
• 지역별 부문 분석 2018-2022년
• 국가별 부문 분석 2018-2022년

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 유형별 시장 세분화

• 시장 세분화
• 비교 : 유형별
• 생물학적 제제 : 시장 규모와 예측 2023-2028년
• 소분자 : 시장 규모와 예측 2023-2028년
• 유형별 시장 기회

제7장 유통 채널별 시장 세분화

• 시장 세분화
• 비교 : 유통 채널별
• 오프라인 : 시장 규모와 예측 2023-2028년
• 온라인 : 시장 규모와 예측 2023-2028년
• 유통 채널별 시장 기회

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측 2023-2028년
• 유럽 : 시장 규모와 예측 2023-2028년
• 아시아 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 미국 : 시장 규모와 예측 2023-2028년
• 독일 : 시장 규모와 예측 2023-2028년
• 영국 : 시장 규모와 예측 2023-2028년
• 캐나다 : 시장 규모와 예측 2023-2028년
• 중국 : 시장 규모와 예측 2023-2028년
• 지역 상황별 시장 기회

제10장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제11장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• BioMarin Pharmaceutical Inc.
• Capricor Therapeutics Inc.
• CRISPR Therapeutics AG
• Daiichi Sankyo Co. Ltd.
• Editas Medicine Inc.
• F. Hoffmann La Roche Ltd.
• Italfarmaco Holding SPA
• Nippon Shinyaku Co. Ltd.
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• PTC Therapeutics Inc.
• Santhera Pharmaceuticals Holding AG
• Sarepta Therapeutics Inc.
• The Cleveland Clinic Foundation
• Wave Life Sciences Ltd.

제13장 부록

영문목차

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028

The duchenne muscular dystrophy (DMD) therapeutics market is forecasted to grow by USD 4373.3 mn during 2023-2028, accelerating at a CAGR of 28.21% during the forecast period. The report on the duchenne muscular dystrophy (DMD) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high unmet need for duchenne muscular dystrophy therapeutics, increasing strategic alliances among the vendors, and introduction of patient assistance programs.

Technavio's duchenne muscular dystrophy (DMD) therapeutics market is segmented as below:

By Type

• Biologics
• Small molecules

By Distribution Channel

• Offline
• Online

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strong pipeline for duchenne muscular dystrophy therapeutics as one of the prime reasons driving the duchenne muscular dystrophy (DMD) therapeutics market growth during the next few years. Also, increasing research funding for duchenne muscular dystrophy therapeutics and special drug designation for duchenne muscular dystrophy (DMD) therapeutics will lead to sizable demand in the market.

The report on the duchenne muscular dystrophy (DMD) therapeutics market covers the following areas:

• Duchenne muscular dystrophy (DMD) therapeutics market sizing
• Duchenne muscular dystrophy (DMD) therapeutics market forecast
• Duchenne muscular dystrophy (DMD) therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading duchenne muscular dystrophy (DMD) therapeutics market vendors that include BioMarin Pharmaceutical Inc., Capricor Therapeutics Inc., CRISPR Therapeutics AG, CVS Health Corp., Daiichi Sankyo Co. Ltd., Editas Medicine Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., FibroGen Inc., Italfarmaco Holding SPA, Nippon Shinyaku Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., PTC Therapeutics Inc., Santhera Pharmaceuticals Holding AG, Sarepta Therapeutics Inc., The Cleveland Clinic Foundation, Vertex Pharmaceuticals Inc., and Wave Life Sciences Ltd.. Also, the duchenne muscular dystrophy (DMD) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Biologics - Market size and forecast 2023-2028
  • Chart on Biologics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
  • Chart on Biologics - Year-over-year growth 2023-2028 (%)
  • Data Table on Biologics - Year-over-year growth 2023-2028 (%)
• 6.4 Small molecules - Market size and forecast 2023-2028
  • Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
  • Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
  • Chart on Small molecules - Year-over-year growth 2023-2028 (%)
  • Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 7.3 Offline - Market size and forecast 2023-2028
  • Chart on Offline - Market size and forecast 2023-2028 ($ million)
  • Data Table on Offline - Market size and forecast 2023-2028 ($ million)
  • Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Data Table on Offline - Year-over-year growth 2023-2028 (%)
• 7.4 Online - Market size and forecast 2023-2028
  • Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Chart on Online - Year-over-year growth 2023-2028 (%)
  • Data Table on Online - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 BioMarin Pharmaceutical Inc.
  • BioMarin Pharmaceutical Inc. - Overview
  • BioMarin Pharmaceutical Inc. - Product / Service
  • BioMarin Pharmaceutical Inc. - Key offerings
• 12.4 Capricor Therapeutics Inc.
  • Capricor Therapeutics Inc. - Overview
  • Capricor Therapeutics Inc. - Product / Service
  • Capricor Therapeutics Inc. - Key offerings
• 12.5 CRISPR Therapeutics AG
  • CRISPR Therapeutics AG - Overview
  • CRISPR Therapeutics AG - Product / Service
  • CRISPR Therapeutics AG - Key offerings
• 12.6 Daiichi Sankyo Co. Ltd.
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Product / Service
  • Daiichi Sankyo Co. Ltd. - Key news
  • Daiichi Sankyo Co. Ltd. - Key offerings
• 12.7 Editas Medicine Inc.
  • Editas Medicine Inc. - Overview
  • Editas Medicine Inc. - Product / Service
  • Editas Medicine Inc. - Key offerings
• 12.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 Italfarmaco Holding SPA
  • Italfarmaco Holding SPA - Overview
  • Italfarmaco Holding SPA - Product / Service
  • Italfarmaco Holding SPA - Key offerings
• 12.10 Nippon Shinyaku Co. Ltd.
  • Nippon Shinyaku Co. Ltd. - Overview
  • Nippon Shinyaku Co. Ltd. - Business segments
  • Nippon Shinyaku Co. Ltd. - Key offerings
  • Nippon Shinyaku Co. Ltd. - Segment focus
• 12.11 Otsuka Holdings Co. Ltd.
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key news
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Segment focus
• 12.12 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.13 PTC Therapeutics Inc.
  • PTC Therapeutics Inc. - Overview
  • PTC Therapeutics Inc. - Product / Service
  • PTC Therapeutics Inc. - Key offerings
• 12.14 Santhera Pharmaceuticals Holding AG
  • Santhera Pharmaceuticals Holding AG - Overview
  • Santhera Pharmaceuticals Holding AG - Product / Service
  • Santhera Pharmaceuticals Holding AG - Key offerings
• 12.15 Sarepta Therapeutics Inc.
  • Sarepta Therapeutics Inc. - Overview
  • Sarepta Therapeutics Inc. - Product / Service
  • Sarepta Therapeutics Inc. - Key offerings
• 12.16 The Cleveland Clinic Foundation
  • The Cleveland Clinic Foundation - Overview
  • The Cleveland Clinic Foundation - Product / Service
  • The Cleveland Clinic Foundation - Key offerings
• 12.17 Wave Life Sciences Ltd.
  • Wave Life Sciences Ltd. - Overview
  • Wave Life Sciences Ltd. - Product / Service
  • Wave Life Sciences Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations